Ziegler Capital Management, LLC Biogen Inc. Transaction History

Ziegler Capital Management, LLC

  • $2.84 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 21, 2020
SELL
$264.77 - $305.71 $3.11 Million - $3.59 Million
-11,757 Closed
0 $0
Q2 2020

Jul 24, 2020
SELL
$258.66 - $342.55 $15 Million - $19.9 Million
-58,179 Reduced 83.19%
11,757 $3.15 Million
Q1 2020

Apr 30, 2020
BUY
$268.85 - $341.04 $18.8 Million - $23.9 Million
69,936 New
69,936 $22.1 Million

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ziegler Capital Management, LLC Portfolio

Follow Ziegler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ziegler Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email